Home > News > Analysts advise option pricing for nano platform plays
January 5th, 2005
Analysts advise option pricing for nano platform plays
Abstract:
As nanotechnology companies move into public markets, early stage companies may lack the revenue visibility usually accompanying startups in more established industries.
It is arguable that a platform technology-based nanotechnology company – what we’ll call pluripotent – deserves a premium valuation: one that exceeds the value of its visible product line. But as shown by the withdrawn IPO of Nanosys – an example of this type of company – public investors may not see it this way.
Source:
smalltimes
Bookmark:
| Related News Press |
Investments/IPO's/Splits
Daikin Industries becomes OCSiAl shareholder July 27th, 2021
INBRAIN Neuroelectronics raises over €14M to develop smart graphene-based neural implants for personalised therapies in brain disorders March 26th, 2021
180 Degree Capital Corp. Issues Second Open Letter to the Board and Shareholders of Enzo Biochem, Inc. March 26th, 2021
 |
||
 |
||
| The latest news from around the world, FREE | ||
 |
||
|
|
||
| Premium Products | ||
 |
||
|
Only the news you want to read!
Learn More |
||
 |
||
|
Full-service, expert consulting
Learn More |
||
|
|
||